Studies show that L-arabinose as a sugar blocker can support healthy blood sugar levels and weight management
Evolva, the Swiss biotech company focused on the research, development, and commercialization of products based on nature, has launched L-arabinose, a natural sugar blocker used in food and beverages and reducing sugar applied in food processing.
Studies show that L-arabinose as a sugar blocker can support healthy blood sugar levels and weight management. It also has potential application as a prebiotic. As reducing sugar, L-arabinose is also frequently applied in the production of savory flavors such as chicken and beef.
Made by fermentation, Evolva’s L-arabinose is fully renewable and sustainable, it has a high-purity level (>99%) and no hydrochloric acid is used in the manufacturing process. L-Arabinose is FEMA GRAS approved for use in food and beverages.
L-Arabinose taste profile is well-suited for use in products such as yogurt, chocolate, soft drinks, ice cream, cereal, power bars and confectionery.
With a wide range of applications, L-arabinose has a current market value of CHF 250 million, which is expected to grow by at least 5% per annum. Evolva is having commercial discussions with major customers, which include first supply volumes for 2021.